Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2020/11/028908
CTRI/2020/11/028908Not yet recruitingPhase 2

Effect of Vamana Dhauti In The Management of Amlapitta- An Exploratory Open Clinical Trial

Dr Vani V Adake1 site in 1 country20 target enrollmentStarted: December 11, 2020Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Enrollment
20
Locations
1
Primary Endpoint
There may be a good reduction in symptomatology of the patient even with the non-pharmacological intervention, so that, the burden of everyday medication could be minimised or reduced to nil.
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Amlapitta adversely affects the quality of life of patients, making it difficult to make dietary choices and causing insomnia even hampering social life and contributes to medical expenses. So, considering the above factors, the clinical study will be conducting to assess the effect of Vamana dhauti, one among the purification procedures explained for upper gastro-intestinal tract, which is very simple to administer, cost effective and feasible in all seasons.

Study Design

Study Type
Interventional
Allocation
Computer generated randomization
Masking
Not Applicable

Eligibility Criteria

Ages
21.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •1 Patients fit for Vamana Dhauti 2 Known cases of Amlapitta.

Exclusion Criteria

  • •1 Known cases of peptic ulcer, duodenal ulcer, carcinoma stomach, cardiac disorders, hypertension, diabetes mellitus, and chronic renal failure.
  • •2 Pregnant and lactating women.

Outcomes

Primary Outcomes

There may be a good reduction in symptomatology of the patient even with the non-pharmacological intervention, so that, the burden of everyday medication could be minimised or reduced to nil.

Time Frame: 18 months

Secondary Outcomes

  • Analysis of the vaanta dravya (Vomitus) for its Organo-leptic and Physico-chemical properties(18 months)

Investigators

Sponsor
Dr Vani V Adake
Sponsor Class
Other [self]

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Phase 2
Treatment of Amlapitta through Yoga
CTRI/2020/11/028908Dr Vani V Adake
Not yet recruiting
Not Applicable
To compare the effect of Nagaradi Kwatha and Yavadi Kwatha in the management of Hyperacidity
CTRI/2023/05/053040Dr Jagruti S Jain88
Recruiting
Phase 1/2
Comparision of two drugs , Madanphala and Jeemutaka in the patients of Amlapitta (non-ulcer Dyspepsia) by Vamana(therapeutic emesis)
CTRI/2017/09/009797Bharati Vidyapeeth Deemed University College of Ayurved Dhankawdi Pune Maharashtra30
Not yet recruiting
Phase 2
Study of Amritadi churna in rheumatoid arthritis.
CTRI/2023/04/051316niversity post graduate institute of ayurveda studies and research jodhpur
Completed
Phase 2
amlapitta management with Abhayadi Vati
CTRI/2019/03/017993Institute for Post graduate Teaching and Research in Ayurveda Gujarat Ayurved University60